PHARMA PI MANAGEMENT
ActiveSummary
PHARMA PI MANAGEMENT has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €733k and a net result of €132k. Equity is growing by ~19.7% per year across the filed fiscal years. Its solvency ranks better than 84% of 8663 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
88
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability89▲+3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 3.74 against 1.38 in 2024; short-term debt: 7.5% and cash: 4.5% of total assets), and 12.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87.9%
Return on assets
15.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 d early
2024
57 d early
2023
43 d early
2022
24 d late
2021
61 d early
2020
61 d early
2019
50 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€733k▲ 22.1%
2024 · €601k
2018: €261k
2019: €242k
2020: €288k
2021: €324k
2022: €423k
2023: €491k
2024: €601k
2018 → 2025
Total assets
€834k▲ 7.4%
2024 · €776k
2018: €647k
2019: €673k
2020: €693k
2021: €671k
2022: €697k
2023: €692k
2024: €776k
2018 → 2025
Net result
€132k▲ 20.8%
2024 · €110k
2018: €33k
2019: €-18k
2020: €45k
2021: €36k
2022: €100k
2023: €68k
2024: €110k
2018 → 2025
Working capital
€171k▲ 261%
2024 · €47k
2018: €-82k
2019: €-73k
2020: €-101k
2021: €-248k
2022: €-162k
2023: €-108k
2024: €47k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€324k-€423k▲ 30.8%€491k▲ 16.0%€601k▲ 22.3%€733k▲ 22.1%
Operating result€62k-€150k▲ 143%€106k▼ 29.5%€169k▲ 60.0%€199k▲ 17.4%
Net result€36k-€100k▲ 177%€68k▼ 32.2%€110k▲ 62.1%€132k▲ 20.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 17% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €834k
Fixed assets
€601k ▼ 0.4%
Current assets
€233k ▲ 35.0%
Equity and liabilities €834k
Equity
€733k ▲ 22.1%
Debt
€101k ▼ 42.6%
Debt's share of the balance-sheet total falls from 22.6% to 12.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€202k▲
2024 · €177k
Cash flow
€136k▲
2024 · €117k
Current ratio
3.74▲
2024 · 1.38
Debt to equity
0.14▼
2024 · 0.29
ROE
18.1%▼
2024 · 18.3%
ROA
15.9%▲
2024 · 14.1%
Interest coverage
20.96▲
2024 · 13.09
Debt ≤ 1 year
€62k▼
2024 · €125k
Debt > 1 year
€36k▼
2024 · €48k
Income taxes
€57k▲
2024 · €46k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€776k€834k▲
Fixed assets21/28€603k€601k▼
Tangible fixed assets22/27€3k€811▼
Furniture and vehicles24€3k€811▼
Financial fixed assets28€600k€600k=
Current assets29/58€173k€233k▲
Amounts receivable within one year40/41€117k€194k▲
Trade receivables40€16k€13k▼
Other amounts receivable41€101k€181k▲
Cash at bank and in hand54/58€54k€37k▼
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€776k€834k▲
Equity10/15€601k€733k▲
Contributions10/11€19k€19k=
Reserves13€582k€715k▲
Distributable reserves133€582k€715k▲
Amounts payable17/49€175k€101k▼
Amounts payable after more than one year17€48k€36k▼
Financial debts170/4€48k€36k▼
Amounts payable within one year42/48€125k€62k▼
Current portion of amounts payable after more than one year42€15k€12k▼
Financial debts43€41k€11k▼
Credit institutions430/8€41k€11k▼
Trade debts44€7k€7k▼
Suppliers440/4€7k€7k▼
Taxes, remuneration and social security45€4k€2k▼
Taxes450/3€4k€2k▼
Other amounts payable47/48€59k€31k▼
Accrued charges and deferred income492/3€2k€2k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€4k▼
Other operating charges640/8€988€1k▲
Gross operating margin9900€178k€203k▲
Operating profit (loss)9901€169k€199k▲
Financial income75/76B€0€200▲
Recurring financial income75€0€200▲
Financial charges65/66B€13k€10k▼
Recurring financial charges65€13k€10k▼
Profit (loss) for the period before taxes9903€156k€189k▲
Income taxes67/77€46k€57k▲
Profit (loss) for the period9904€110k€132k▲
Profit (loss) for the period to be appropriated9905€110k€132k▲
Appropriation of the result
Profit (loss) to be appropriated9906€110k€132k▲
Transfer to equity691/2€110k€132k▲
To other reserves6921€110k€132k▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €132k ▲20.8%
Operating result €199k, net result €132k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 3.74
Current ratio from 1.38 to 3.74; short-term debt falls from €125k to €62k.
04-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity triplescurrent ratio 1.38
Current ratio from 0.43 to 1.38; short-term debt falls from €189k to €125k.
31-12
Financial
Equity above €500kEq €601k ▲22.3%
5 profitable years in a row build equity to €601k.
18-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
24-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 24 days late
2022
31-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-05
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Back to profitnet €45k
Net result €45k after one loss-making year.
11-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
Show earlier events
2019
31-12
Financial
Weakest financial yearnet €-18k ▼156%
Net result drops to €-18k, the lowest in the series; recovery starts the following year.
19-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
14-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
02-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tienen · 1 establishment unit since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hannuitsesteenweg 553300 TienenGround area
752 m²
Building footprint
214 m²
Volume, LiDAR
1,659 m³
Parcel 24015M0044/00Z000, Flanders · tallest building 12.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PHARMA PI MANAGEMENT
since 20072.166.590.713
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24015M0044/00Z000 | Flanders | 752 m² | 1 · 214 m² | 12.6 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GUY VAN HERZELE
BE 0472.312.202
Aalst · Eq €733,211
IY REAL ESTATE
BE 0742.680.104
Zaventem · Eq €733,375
THUIS IN MILIEU - ADVIES
BE 0472.201.443
Geel · Eq €733,401
WALLGLASS
BE 0722.928.528
Fleurus · Eq €733,464
LARK INVEST
BE 0713.728.275
Zedelgem · Eq €732,942
Of 82,562 companies in sector 70200 we hold annual accounts for 52,574. 31,103 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-10-2007
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.